- Home
- WLGS vs NCNA Comparison
WLGS vs NCNA Comparison
Compare WLGS & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- NCNA
- Stock Information
- Founded
- WLGS 1981
- NCNA 1997
- Country
- WLGS Hong Kong
- NCNA United Kingdom
- Employees
- WLGS N/A
- NCNA N/A
- Industry
- WLGS Engineering & Construction
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- WLGS Consumer Discretionary
- NCNA Health Care
- Exchange
- WLGS Nasdaq
- NCNA Nasdaq
- Market Cap
- WLGS 4.2M
- NCNA 4.5M
- IPO Year
- WLGS 2023
- NCNA 2017
- Fundamental
- Price
- WLGS $0.17
- NCNA $0.04
- Analyst Decision
- WLGS
- NCNA Buy
- Analyst Count
- WLGS 0
- NCNA 2
- Target Price
- WLGS N/A
- NCNA $25.00
- AVG Volume (30 Days)
- WLGS 1.6M
- NCNA 20.6M
- Earning Date
- WLGS 05-20-2025
- NCNA 05-19-2025
- Dividend Yield
- WLGS N/A
- NCNA N/A
- EPS Growth
- WLGS N/A
- NCNA N/A
- EPS
- WLGS 0.02
- NCNA N/A
- Revenue
- WLGS $7,272,879.00
- NCNA N/A
- Revenue This Year
- WLGS N/A
- NCNA N/A
- Revenue Next Year
- WLGS N/A
- NCNA N/A
- P/E Ratio
- WLGS $9.12
- NCNA N/A
- Revenue Growth
- WLGS 66.93
- NCNA N/A
- 52 Week Low
- WLGS $0.15
- NCNA $0.10
- 52 Week High
- WLGS $9.66
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- WLGS 28.36
- NCNA 34.61
- Support Level
- WLGS $0.15
- NCNA $0.41
- Resistance Level
- WLGS $0.19
- NCNA $0.42
- Average True Range (ATR)
- WLGS 0.02
- NCNA 0.13
- MACD
- WLGS 0.13
- NCNA -0.06
- Stochastic Oscillator
- WLGS 27.47
- NCNA 0.21
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.